DDIS-02. AN ENGINEERED IN VITRO SYNTHESIZED PROTEIN ZR30 EXPRESSES ITS ANTI-CANCER EFFECT IN THE EXTRACELLULAR COMPARTMENT OF DIFFERENT GLIOMA CELL SUBPOPULATIONS IN INTRACRANIAL XENOGRAFT MODELS
Yanyan Li(Central South University), Yihong Zhou(Soochow University), Chuaniin Liu(Soochow University), Kambiz Afrasiabi(University of California, Irvine), Qingyue Wang(Tianjin University), Mark E. Linskey(University of California, Irvine), Yong Han(Xi'an Jiaotong University), Xiaoxiao Han(Zhejiang Chinese Medical University), Xionghui Chen(Soochow University), Eric R. Siegel(University of Arkansas for Medical Sciences)
Cited by 0
Related Papers
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy
|Cancer Medicine|2018|703
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
|Journal of Neuro-Oncology|2009|514
Recent Advances in 3D Printing of Smart Scaffolds for Bone Tissue Engineering and Regeneration
|Advanced Materials|2024|312
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
|Molecular Cancer|2022|129